#China #Xi'an #Veterinary Diagnostics #KHB Group #FOCUS PEGASUS

Introduction

KHB Group recently showcased its advanced veterinary diagnostic analyzer, the FOCUS PEGASUS MF200, at an event in Xi'an, China on November 14, 2025. This state-of-the-art device integrates multiple testing modalities into a single, compact system aimed at modern veterinary clinics. The FOCUS PEGASUS MF200 is designed to enhance diagnostic efficiency, accuracy, and accessibility for practitioners dealing with animal health.

Features and Benefits

The MF200 represents a significant leap in veterinary diagnostics. Combining biochemical testing, electrolytes, coagulation, and immunofluorescence into one platform, it allows veterinarians to perform multiple tests seamlessly. Here are some highlighted features:

• - 4-in-1 Testing Platform: The device consolidates four types of tests, enabling quick decision-making based on comprehensive diagnostics.
• - Streamlined Operation: With a one-step workflow that provides results in just ten minutes, it drastically reduces wait times for veterinarians and pet owners alike.
• - Extensive Test Menu: Covering over 90% of standard pet diagnoses, the MF200 addresses a wide array of common health concerns, making it an indispensable tool in veterinary practices.
• - Safe for Animals: The analyzer requires only a small sample size of 100 μL, ensuring the testing process is quick, safe, and minimizes stress for the animals.
• - Automated System: It handles dilutions, centrifugation, and QR code scanning autonomously, reducing human error and increasing reliability in test results.

User Experience

The MF200 also features an intuitive interface and customizable reporting, making it user-friendly for veterinarians who may not be tech-savvy. This emphasis on ease of use enhances daily veterinary tasks, allowing professionals to focus more on patient care rather than cumbersome administrative tasks.

Market Impact

Having already made waves in Asian and North American markets, the MF200 signifies a breakthrough in point-of-care testing. Scheduled to be featured at MEDICA 2025, its unveiling underscores KHB's commitment to advancing the field of veterinary diagnostics. As Li Ming, CEO of KHB Group, stated, "The MF200 is the next evolution in intelligent veterinary testing - a compact solution that redefines diagnostic efficiency. Our mission is to provide veterinary professionals with speed, accuracy, and confidence with every test result."

About KHB Group

Shanghai Kehua Bio-engineering Co., Ltd. (KHB) is a pioneering in vitro diagnostics (IVD) company focusing on immunological, biochemical, molecular diagnostics, and point-of-care testing solutions since its establishment in 1981. With its dedication to research, development, manufacturing, and commercialization, KHB has positioned itself as a high-tech leader, successfully listed on the Shenzhen Stock Exchange (SZSE) in 2004. The establishment of its subsidiary, Guangzhou Focus Biotechnology Co., Ltd. in 2023, aims to specialize in veterinary POCT solutions and aspire to be a global leader in animal health diagnostics. For further details, please visit KHB’s official website and their social media platforms for the latest updates.

In conclusion, the revolutionary FOCUS PEGASUS MF200 is set to elevate veterinary diagnostics, ensuring that pet health care remains a top priority with innovative, reliable, and accessible solutions.